TP53 tumor suppressor gene: a model for investigating human mutagenesis (Q35323631)

7 August 2017

1 reference

title

TP53 tumor suppressor gene: a model for investigating human mutagenesis (English)

1 reference

7 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1377002

Claude Caron De Fromentel

20 September 2022

author

series ordinal

1

object named as

C. Caron de Fromentel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1377002

20 September 2022

2

T. Soussi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1377002

20 September 2022

author name string

Caron de Fromentel C

series ordinal

1

1 reference

7 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1377002

20 September 2022

publication date

1 January 1992

1 reference

Genes, Chromosomes and Cancer

7 August 2017

published in

1 reference

7 August 2017

volume

4

1 reference

7 August 2017

issue

1

1 reference

7 August 2017

page(s)

1-15

1 reference

Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870040102

The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870040102

7 January 2021

Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870040102

7 January 2021

Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870040102

7 January 2021

Molecular basis of base substitution hotspots in Escherichia coli

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870040102

7 January 2021

Genetic basis for p53 overexpression in human breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870040102

7 January 2021

Carcinogenic epoxides of benzo[a]pyrene and cyclopenta[cd]pyrene induce base substitutions via specific transversions

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870040102

7 January 2021

p53 in chronic myelogenous leukemia in acute phase

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870040102

7 January 2021

Presence of a potent transcription activating sequence in the p53 protein

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870040102

7 January 2021

A splicing mutation accounts for the lack of p53 gene expression in a CML blast crisis cell line: a novel mechanism of p53 gene inactivation

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870040102

7 January 2021

p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870040102

7 January 2021

Telling changes of base

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870040102

7 January 2021

Frequent mutation of the p53 gene in human esophageal cancer

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870040102

7 January 2021

p53 mutations in human cancers

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870040102

7 January 2021

Mutational hot spot in the p53 gene in human hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870040102

7 January 2021

Increased expression of mutant forms of p53 oncogene in primary lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870040102

7 January 2021

Occurrence of p53 gene abnormalities in gastric carcinoma tumors and cell lines

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870040102

7 January 2021

p53: oncogene or anti-oncogene?

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870040102

7 January 2021

Tumor suppressor genes

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870040102

7 January 2021

The p53 tumour suppressor gene

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870040102

7 January 2021

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870040102

7 January 2021

Selective removal of transcription-blocking DNA damage from the transcribed strand of the mammalian DHFR gene

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870040102

7 January 2021

Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870040102

7 January 2021

Identification of a germ-line mutation in the p53 gene in a patient with an intracranial ependymoma

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870040102

7 January 2021

p53 mutations: gains or losses?

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870040102

7 January 2021

Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870040102

7 January 2021

Mechanisms of p53 loss in human sarcomas

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870040102

7 January 2021

Mutations in the p53 gene occur in diverse human tumour types

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870040102

7 January 2021

Frequency of abnormal human haemoglobins caused by C----T transitions in CpG dinucleotides

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870040102

7 January 2021

Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870040102

7 January 2021

5-Methylcytosine as an Endogenous Mutagen in the Human LDL Receptor and p53 Genes

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870040102

7 January 2021

p53 mutations in colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870040102

7 January 2021

Point mutation of the p53 gene resulting in splicing inhibition in small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870040102

7 January 2021

The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870040102

7 January 2021

Identification of p53 gene mutations in bladder cancers and urine samples

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870040102

7 January 2021

https://api.crossref.org/works/10.1002%2FGCC.2870040102

1 reference

7 January 2021

Nucleotide sequence of a cDNA encoding the chicken p53 nuclear oncoprotein

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870040102

7 January 2021

Nucleotide sequence of a cDNA encoding the rat p53 nuclear oncoprotein.

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870040102

7 January 2021

Evolutionary conservation of the biochemical properties of p53: specific interaction of Xenopus laevis p53 with simian virus 40 large T antigen and mammalian heat shock proteins 70

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870040102

7 January 2021

Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870040102

7 January 2021

The expected equilibrium of the CpG dinucleotide in vertebrate genomes under a mutation model

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870040102

7 January 2021

p53: a frequent target for genetic abnormalities in lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870040102

7 January 2021

Identification of intronic point mutations as an alternative mechanism for p53 inactivation in lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FGCC.2870040102

7 January 2021

Identifiers

DOI

10.1002/GCC.2870040102

1 reference

7 August 2017

1 reference